Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
10.18
-0.22 (-2.12%)
May 20, 2026, 11:44 AM CST

SHE:002399 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,7871,3461,6891,7662,1392,944
Short-Term Investments
---206.2--
Trading Asset Securities
1,7181,484868.42414.181,312981.16
Cash & Short-Term Investments
3,5052,8302,5572,3863,4503,925
Cash Growth
12.99%10.66%7.18%-30.85%-12.10%8.59%
Accounts Receivable
1,3661,3681,1871,2751,6261,543
Other Receivables
18.24301.39329.63121.89134.82243.81
Receivables
1,3841,6691,5161,3961,7611,787
Inventory
4,1834,4475,3946,6546,8444,708
Prepaid Expenses
---111.28--
Other Current Assets
508.67205.25153.4356.43334.53349.43
Total Current Assets
9,5809,1519,62110,60412,39010,770
Property, Plant & Equipment
2,3132,3882,6482,8492,4772,537
Long-Term Investments
1,7391,7661,8232,5142,4642,618
Goodwill
2,2692,3052,3572,3222,3512,152
Other Intangible Assets
308.99326.57400.41370.78522.87546.87
Long-Term Deferred Tax Assets
315.8320.44282.51320.5141.48121.72
Long-Term Deferred Charges
172.92178.96185.6518.64244.71241.88
Other Long-Term Assets
313.95195.3225.48203.87224.95120.85
Total Assets
17,01316,63217,34419,20320,81619,108
Accounts Payable
288.76257.07299.69306.34427.43385.79
Accrued Expenses
88.22469.4399.46388377.51398.43
Short-Term Debt
2,7241,7701,8391,0692,3851,886
Current Portion of Long-Term Debt
471.05834.59528.222,5561,6351,382
Current Portion of Leases
-30.138.8237.835.6931.75
Current Income Taxes Payable
139.66107.32120.26157.18112.3113.2
Current Unearned Revenue
230.14250.79264.28362.05433.88383.79
Other Current Liabilities
513.28233.65209.56110.24168.2210.34
Total Current Liabilities
4,4553,9533,6994,9865,5764,791
Long-Term Debt
28.71298.061,0811,8102,2972,250
Long-Term Leases
35.4440.3257.7790.42110.75104
Long-Term Unearned Revenue
40.8942.5827.2830.4332.5516.67
Pension & Post-Retirement Benefits
--23.2235.2732.49120.65
Long-Term Deferred Tax Liabilities
214.17207.07242.49252.57328.92275.36
Other Long-Term Liabilities
10.0510.1910.3510.1529.3926.44
Total Liabilities
4,7844,5525,1417,2158,4077,585
Common Stock
1,4671,4671,4671,4671,4671,467
Additional Paid-In Capital
5,8645,8645,8657,5295,8595,944
Retained Earnings
4,7534,5664,5783,9414,8614,184
Comprehensive Income & Other
95.2133.96238.17-1,024125.52-183.36
Total Common Equity
12,18012,03112,14911,91312,31311,411
Minority Interest
48.9849.2353.4575.2396.72111.96
Shareholders' Equity
12,22912,08012,20211,98812,40911,523
Total Liabilities & Equity
17,01316,63217,34419,20320,81619,108
Total Debt
3,2592,9743,5455,5636,4645,654
Net Cash (Debt)
245.95-143.41-987.34-3,177-3,013-1,729
Net Cash Per Share
0.17-0.10-0.67-2.15-2.05-1.18
Filing Date Shares Outstanding
1,4681,4671,4671,4671,4671,467
Total Common Shares Outstanding
1,4681,4671,4671,4671,4671,467
Working Capital
5,1255,1985,9225,6186,8145,978
Book Value Per Share
8.308.208.288.128.397.78
Tangible Book Value
9,6029,4009,3919,2209,4398,712
Tangible Book Value Per Share
6.546.416.406.286.435.94
Land
-33.7434.513433.4330.61
Buildings
-1,8371,7881,9151,4801,450
Machinery
-2,5051,9961,9611,8921,719
Construction In Progress
-60.7697.77468.72394.53425.35
Leasehold Improvements
---15.43--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.